MedPath

Primary Progressive Aphasia Multicomponent Language Treatment Study

Not Applicable
Active, not recruiting
Conditions
Primary Progressive Aphasia
Semantic Dementia
Semantic Memory Disorder
Logopenic Progressive Aphasia
Nonfluent Aphasia, Progressive
Aphasia
Aphasia, Progressive
Registration Number
NCT06649084
Lead Sponsor
University of Texas at Austin
Brief Summary

Primary progressive aphasia (PPA) is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurodegeneration of speech and language networks in the brain. PPA is a devastating condition affecting adults as young as in their 50's, depriving them of the ability to communicate and function in society. As a result of improved diagnostic precision, PPA is now identified with greater accuracy and frequency and, increasingly, patients and their families seek options for behavioral treatments to ameliorate the devastating effects on their communication, prolong speech language skills, and maximize quality of life. Speech-language treatment outcomes from our group and others are encouraging, confirming that behavioral intervention may lead to improvements in trained behaviors and, for some interventions, lasting and generalized benefit. Most speech-language interventions for individuals with PPA that have been explored in the literature are restitutive, or impairment-based in nature, and have not addressed the full range of severity and phenotypic variability in this population. The investigators will evaluate the utility of a novel, multicomponent intervention that incorporates elements of restitutive (e.g., word finding strategic training, script training), compensatory (e.g., multimodal communication, communication book), and care partner-focused treatment to meet the needs of individuals varying in clinical presentation and severity.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
  • Scores of 10 or higher on the Mini-Mental State Examination
  • Has a study partner who can consistently attend sessions
Exclusion Criteria
  • Other neurological or psychiatric diagnosis that may contribute to cognitive-linguistic deficits
  • Significant, uncorrected visual or hearing impairment that would interfere with participation
  • Score of less than 10 on the Mini-Mental State Examination
  • Prominent initial non-speech-language impairment (cognitive, behavioral, motoric)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in script production accuracychange from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

Percent correct intelligible, scripted words for trained/untrained scripts

Change in spoken naming of trained/untrained itemschange from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

Percent correctly named trained/untrained pictures

Information communicated in any modality for trained/untrained stimulichange from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

Percent of major content units (key words) communicated via speech or nonspeech modalities (e.g., writing, drawing, gesture) for trained/untrained scripts (Multi-VISTA) or words (Multi-LRT) during structured probes and in conversation

Goal Attainment Scorechange from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

The Goal Attainment Score is self-reported progress on personalized goals based on a five point scale.

Secondary Outcome Measures
NameTimeMethod
Change on Quick Aphasia Batterychange from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

change on standardized aphasia assessment

Change on Aphasia Impact Questionnairechange from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

change on psychosocial questionnaire for individuals with aphasia

Trial Locations

Locations (1)

University of Texas

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath